Correspondence to: Janhavi Venkataraman (email: Janhavi.Venkakataraman@hcahealthcare.co.uk; janhavivraman@gmail.com)
The London Breast Institute
Princess Grace Hospital
42-52 Nottingham Place
London
W1U 5NY
UK
____
BJS, https://doi.org/10.1093/bjs/znaf032, published 25 February 2025
_____
Dear Editor
The article by Harvey et al. on patient-reported outcomes (PROs) following prepectoral implant-based breast reconstruction in the UK (Pre-BRA study)1 is valuable, but several methodological considerations must be addressed to improve interpretation and applicability.
A primary concern is the heterogeneity of surgical techniques. Variability in the use of biological mesh and single- versus two-stage reconstruction affects generalizability. Notably, patients without biological mesh face higher risks of complications such as rippling, while acellular dermal matrix (ADM) can mitigate this issue, enhancing aesthetics and satisfaction. In our prospective study of 72 patients with ADM-assisted prepectoral reconstruction, we observed a low complication rate (2.8%) and no cases of significant rippling requiring fat grafting or implant loss after 18.3 months2.
Surgeon expertise and technique further influence PROs. The multicenter nature of the study introduces variability, limiting direct applicability to specific institutions. Vidya et al.3 proposed a grading system for rippling severity (1–4), highlighting the benefits of cohesive gel implants and ADM in patients with thin skin flaps. Implementing this system and incorporating lipomodelling for grades 2–4 could improve outcomes.
Moreover, the study lacks adjustments for confounders like radiation and comorbidities, which can affect PROs. Multivariable analysis or propensity score matching could improve validity. Long-term follow-up is crucial to assess complications like late rippling or capsular contracture.
Future studies should standardize surgical approaches, particularly regarding biological mesh in single-stage reconstructions, to ensure reproducibility, and include subgroup analyses, where possible. The inclusion of a control group (e.g., subpectoral reconstruction or no reconstruction) could improve conclusions about the prepectoral technique’s benefits.
Disclosure:
K.M. has received honoraria for offering academic and clinical advice to Merit Medical. The other authors declare no conflict of interest.
References
Harvey KL, Johnson L, Sinai P, Mills N, White P, Holcombe C, Potter S; Pre-BRA Feasibility Study Steering Group. Patient-reported outcomes 3 and 18 months after mastectomy and immediate prepectoral implant-based breast reconstruction in the UK Pre-BRA prospective multicenter cohort study. BJS 2025;112, doi: 10.1093/bjs/znaf032.
Wazir U, Patani N, Heeney J, Mokbel K, Mokbel K. Pre-pectoral Immediate Breast Reconstruction Following Conservative Mastectomy Using Acellular Dermal Matrix and Semi-smooth Implants. Anticancer Res 2022;42:1013-1018. doi: 10.21873/anticanres.
Vidya R, Iqbal FM, Becker H, Zhadan O. Rippling Associated with Pre-Pectoral Implant-Based Breast Reconstruction: A New Grading System. World J Plast Surg 2019;8:311-315. doi: 10.29252/wjps.8.3.311.






.png)





.jpg)




